ArticleBlood advances2026
A phase 1/1b study of the all-oral regimen CC-486 and venetoclax in acute myeloid leukemia.
Maria L Amaya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleBlood advances2026
Maria L Amaya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.